NewslettersImmunology of Infectious Disease NewsProxalutamide Reduces SARS-CoV-2 Infection and Associated Inflammatory ResponseBy Bob - July 19, 2023049Researchers examined the ability of proxalutamide, an androgen receptor antagonist, to impact SARS-CoV-2 infection and downstream inflammatory responses.[Proceedings Of The National Academy Of Sciences Of The United States Of America]Full Article